Editas Medicine Inc (EDIT)
2.455
+0.08
(+3.59%)
USD |
NASDAQ |
Nov 22, 14:36
Editas Medicine Total Assets (Quarterly): 327.57M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 327.57M |
| June 30, 2024 | 384.80M |
| March 31, 2024 | 440.35M |
| December 31, 2023 | 499.15M |
| September 30, 2023 | 504.65M |
| June 30, 2023 | 541.95M |
| March 31, 2023 | 464.10M |
| December 31, 2022 | 514.32M |
| September 30, 2022 | 531.03M |
| June 30, 2022 | 580.83M |
| March 31, 2022 | 623.11M |
| December 31, 2021 | 677.48M |
| September 30, 2021 | 717.02M |
| June 30, 2021 | 755.88M |
| March 31, 2021 | 780.29M |
| December 31, 2020 | 572.60M |
| September 30, 2020 | 597.16M |
| June 30, 2020 | 655.48M |
| March 31, 2020 | 466.74M |
| Date | Value |
|---|---|
| December 31, 2019 | 508.88M |
| September 30, 2019 | 372.36M |
| June 30, 2019 | 355.62M |
| March 31, 2019 | 378.92M |
| December 31, 2018 | 420.39M |
| September 30, 2018 | 387.63M |
| June 30, 2018 | 393.53M |
| March 31, 2018 | 403.98M |
| December 31, 2017 | 373.26M |
| September 30, 2017 | 339.13M |
| June 30, 2017 | 368.85M |
| March 31, 2017 | 395.04M |
| December 31, 2016 | 229.18M |
| September 30, 2016 | 242.15M |
| June 30, 2016 | 249.60M |
| March 31, 2016 | 248.81M |
| December 31, 2015 | 149.36M |
| September 30, 2015 | 159.74M |
| December 31, 2014 | 12.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
327.57M
Minimum
Sep 2024
780.29M
Maximum
Mar 2021
557.17M
Average
536.49M
Median
Total Assets (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 3.081B |
| EyePoint Pharmaceuticals Inc | 300.92M |
| Cassava Sciences Inc | 223.75M |
| Adverum Biotechnologies Inc | 234.38M |
| Regenxbio Inc | 519.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 151.93M |
| Shareholders Equity (Quarterly) | 175.63M |
| Current Ratio | 3.747 |